Back to Search
Start Over
World Tuberculosis Day 2022: aligning COVID-19 and tuberculosis innovations to save lives and to end tuberculosis.
- Source :
-
The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Apr; Vol. 22 (4), pp. 442-444. Date of Electronic Publication: 2022 Mar 03. - Publication Year :
- 2022
-
Abstract
- Competing Interests: KGC declares salary support to serve as US Agency for International Development (USAID) senior tuberculosis scientific advisor through an intergovernmental personnel act award between Emory University and USAID. AZ, FN, and DY-M acknowledge support from the EU-EDCTP funded PANDORA-ID-NET, CANTAM-3, and EACCR-3 programmes. AZ is in receipt of a UK National Institute for Health Research Senior Investigator Award. JBN acknowledges support from the US National Institutes of Health (NIH) Fogarty International Center (grants 1R25TW011217-01, 1R21TW011706-01, and 1D43TW010937-01A1) and NIH National Institute of Allergy and Infectious Diseases (grant U01 AI096299). All other authors declare no competing interests. All authors have a specialist interest in global epidemics of COVID-19, tuberculosis, and HIV. The views expressed in this editorial are entirely those of the authors and do not reflect the views of their respective institutions.
- Subjects :
- Humans
COVID-19
Tuberculosis drug therapy
Tuberculosis prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1474-4457
- Volume :
- 22
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- The Lancet. Infectious diseases
- Publication Type :
- Academic Journal
- Accession number :
- 35248166
- Full Text :
- https://doi.org/10.1016/S1473-3099(22)00142-6